Microfluidics show promise as safer, simpler treatment option for severe neonatal jaundice

Namibia detects 18 Omicron cases, destroys 150,000 jabs
6 December 2021
Targeted nanomedicine reduces vascular lesions, could help prevent stenosis
6 December 2021

Microfluidics show promise as safer, simpler treatment option for severe neonatal jaundice

Research by the Oregon State University College of Engineering has led to a promising potential therapy for neonatal jaundice that’s more safe, simple and convenient than the blood transfusions currently given to babies suffering from the most dangerous forms of the condition.

Comments are closed.